出血性敗血症ワクチンのグローバル市場調査 2019年

• レポートコード：QYR9NV05965
• 出版社/出版日：QYResearch / 2019年11月12日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、110ページ
• 納品方法：Eメール（受注後2-3営業日）
• 産業分類：医薬品・ヘルスケア

• 販売価格（消費税別）

Single User	￥525,000 (USD3,500)	▷ お問い合わせ
Enterprise License	￥1,050,000 (USD7,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

※本調査レポートは、出血性敗血症ワクチンの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、オイルアジュバントワクチン、水酸化アルミニウムアジュバントワクチンに、用途別には、牛、水牛にセグメント区分し、出血性敗血症ワクチンの世界市場を分析しました。

・エグゼクティブ・サマリー
・出血性敗血症ワクチンの世界市場概要
・出血性敗血症ワクチンの製造コスト構成分析
・出血性敗血症ワクチンの開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・出血性敗血症ワクチンの地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・出血性敗血症ワクチンのセグメント分析（種類別）
（オイルアジュバントワクチン、水酸化アルミニウムアジュバントワクチン）
・出血性敗血症ワクチンのセグメント分析（用途別）
（牛、水牛）
・出血性敗血症ワクチンの主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Bio-Labs (PVT) Limited、Brilliant Bio Pharma、C.A. Laboratorios Asociados (CALA)、Ceva Santé Animale、Vecol、FATRO、Indian Immunologicals Limited、Institute of Animal Health and Veterinary Biologicals、Institute of Veterinary Preventive Medicine、Intervac (PVT) Ltd、LABIOFAM、Laboratorios Laverlam、Laboratorios Ovejero、Limor de Colombia、National Veterinary Research Institute、Zoetis、）
・出血性敗血症ワクチンの市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...

The global Hemorrhagic Septicemia Vaccines market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Hemorrhagic Septicemia Vaccines volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hemorrhagic Septicemia Vaccines market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Hemorrhagic Septicemia Vaccines in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Hemorrhagic Septicemia Vaccines manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Bio-Labs (PVT) Limited
Brilliant Bio Pharma
C.A. Laboratorios Asociados (CALA)
Ceva Santé Animale
Vecol
FATRO
Indian Immunologicals Limited
Institute of Animal Health and Veterinary Biologicals
Institute of Veterinary Preventive Medicine
Intervac (PVT) Ltd
LABIOFAM
Laboratorios Laverlam
Laboratorios Ovejero
Limor de Colombia
National Veterinary Research Institute
Zoetis

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Oil–adjuvant Vaccines
Aluminum hydroxide-adjuvant Vaccines

Segment by Application
Cattle
Buffaloes

レポート目次

Table of Contents

Executive Summary
1 Industry Overview of Hemorrhagic Septicemia Vaccines
1.1 Definition of Hemorrhagic Septicemia Vaccines
1.2 Hemorrhagic Septicemia Vaccines Segment by Type
1.2.1 Global Hemorrhagic Septicemia Vaccines Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Oil–adjuvant Vaccines
1.2.3 Aluminum hydroxide-adjuvant Vaccines
1.3 Hemorrhagic Septicemia Vaccines Segment by Applications
1.3.1 Global Hemorrhagic Septicemia Vaccines Consumption Comparison by Applications (2014-2025)
1.3.2 Cattle
1.3.3 Buffaloes
1.4 Global Hemorrhagic Septicemia Vaccines Overall Market
1.4.1 Global Hemorrhagic Septicemia Vaccines Revenue (2014-2025)
1.4.2 Global Hemorrhagic Septicemia Vaccines Production (2014-2025)
1.4.3 North America Hemorrhagic Septicemia Vaccines Status and Prospect (2014-2025)
1.4.4 Europe Hemorrhagic Septicemia Vaccines Status and Prospect (2014-2025)
1.4.5 China Hemorrhagic Septicemia Vaccines Status and Prospect (2014-2025)
1.4.6 Japan Hemorrhagic Septicemia Vaccines Status and Prospect (2014-2025)
1.4.7 Southeast Asia Hemorrhagic Septicemia Vaccines Status and Prospect (2014-2025)
1.4.8 India Hemorrhagic Septicemia Vaccines Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Hemorrhagic Septicemia Vaccines
2.3 Manufacturing Process Analysis of Hemorrhagic Septicemia Vaccines
2.4 Industry Chain Structure of Hemorrhagic Septicemia Vaccines

3 Development and Manufacturing Plants Analysis of Hemorrhagic Septicemia Vaccines
3.1 Capacity and Commercial Production Date
3.2 Global Hemorrhagic Septicemia Vaccines Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Hemorrhagic Septicemia Vaccines
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Hemorrhagic Septicemia Vaccines Production and Capacity Analysis
4.2 Hemorrhagic Septicemia Vaccines Revenue Analysis
4.3 Hemorrhagic Septicemia Vaccines Price Analysis
4.4 Market Concentration Degree

5 Hemorrhagic Septicemia Vaccines Regional Market Analysis
5.1 Hemorrhagic Septicemia Vaccines Production by Regions
5.1.1 Global Hemorrhagic Septicemia Vaccines Production by Regions
5.1.2 Global Hemorrhagic Septicemia Vaccines Revenue by Regions
5.2 Hemorrhagic Septicemia Vaccines Consumption by Regions
5.3 North America Hemorrhagic Septicemia Vaccines Market Analysis
5.3.1 North America Hemorrhagic Septicemia Vaccines Production
5.3.2 North America Hemorrhagic Septicemia Vaccines Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Hemorrhagic Septicemia Vaccines Import and Export
5.4 Europe Hemorrhagic Septicemia Vaccines Market Analysis
5.4.1 Europe Hemorrhagic Septicemia Vaccines Production
5.4.2 Europe Hemorrhagic Septicemia Vaccines Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Hemorrhagic Septicemia Vaccines Import and Export
5.5 China Hemorrhagic Septicemia Vaccines Market Analysis
5.5.1 China Hemorrhagic Septicemia Vaccines Production
5.5.2 China Hemorrhagic Septicemia Vaccines Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Hemorrhagic Septicemia Vaccines Import and Export
5.6 Japan Hemorrhagic Septicemia Vaccines Market Analysis
5.6.1 Japan Hemorrhagic Septicemia Vaccines Production
5.6.2 Japan Hemorrhagic Septicemia Vaccines Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Hemorrhagic Septicemia Vaccines Import and Export
5.7 Southeast Asia Hemorrhagic Septicemia Vaccines Market Analysis
5.7.1 Southeast Asia Hemorrhagic Septicemia Vaccines Production
5.7.2 Southeast Asia Hemorrhagic Septicemia Vaccines Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Hemorrhagic Septicemia Vaccines Import and Export
5.8 India Hemorrhagic Septicemia Vaccines Market Analysis
5.8.1 India Hemorrhagic Septicemia Vaccines Production
5.8.2 India Hemorrhagic Septicemia Vaccines Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Hemorrhagic Septicemia Vaccines Import and Export

6 Hemorrhagic Septicemia Vaccines Segment Market Analysis (by Type)
6.1 Global Hemorrhagic Septicemia Vaccines Production by Type
6.2 Global Hemorrhagic Septicemia Vaccines Revenue by Type
6.3 Hemorrhagic Septicemia Vaccines Price by Type

7 Hemorrhagic Septicemia Vaccines Segment Market Analysis (by Application)
7.1 Global Hemorrhagic Septicemia Vaccines Consumption by Application
7.2 Global Hemorrhagic Septicemia Vaccines Consumption Market Share by Application (2014-2019)

8 Hemorrhagic Septicemia Vaccines Major Manufacturers Analysis
8.1 Bio-Labs (PVT) Limited
8.1.1 Bio-Labs (PVT) Limited Hemorrhagic Septicemia Vaccines Production Sites and Area Served
8.1.2 Bio-Labs (PVT) Limited Product Introduction, Application and Specification
8.1.3 Bio-Labs (PVT) Limited Hemorrhagic Septicemia Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Brilliant Bio Pharma
8.2.1 Brilliant Bio Pharma Hemorrhagic Septicemia Vaccines Production Sites and Area Served
8.2.2 Brilliant Bio Pharma Product Introduction, Application and Specification
8.2.3 Brilliant Bio Pharma Hemorrhagic Septicemia Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 C.A. Laboratorios Asociados (CALA)
8.3.1 C.A. Laboratorios Asociados (CALA) Hemorrhagic Septicemia Vaccines Production Sites and Area Served
8.3.2 C.A. Laboratorios Asociados (CALA) Product Introduction, Application and Specification
8.3.3 C.A. Laboratorios Asociados (CALA) Hemorrhagic Septicemia Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Ceva Santé Animale
8.4.1 Ceva Santé Animale Hemorrhagic Septicemia Vaccines Production Sites and Area Served
8.4.2 Ceva Santé Animale Product Introduction, Application and Specification
8.4.3 Ceva Santé Animale Hemorrhagic Septicemia Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Vecol
8.5.1 Vecol Hemorrhagic Septicemia Vaccines Production Sites and Area Served
8.5.2 Vecol Product Introduction, Application and Specification
8.5.3 Vecol Hemorrhagic Septicemia Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 FATRO
8.6.1 FATRO Hemorrhagic Septicemia Vaccines Production Sites and Area Served
8.6.2 FATRO Product Introduction, Application and Specification
8.6.3 FATRO Hemorrhagic Septicemia Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Indian Immunologicals Limited
8.7.1 Indian Immunologicals Limited Hemorrhagic Septicemia Vaccines Production Sites and Area Served
8.7.2 Indian Immunologicals Limited Product Introduction, Application and Specification
8.7.3 Indian Immunologicals Limited Hemorrhagic Septicemia Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Institute of Animal Health and Veterinary Biologicals
8.8.1 Institute of Animal Health and Veterinary Biologicals Hemorrhagic Septicemia Vaccines Production Sites and Area Served
8.8.2 Institute of Animal Health and Veterinary Biologicals Product Introduction, Application and Specification
8.8.3 Institute of Animal Health and Veterinary Biologicals Hemorrhagic Septicemia Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Institute of Veterinary Preventive Medicine
8.9.1 Institute of Veterinary Preventive Medicine Hemorrhagic Septicemia Vaccines Production Sites and Area Served
8.9.2 Institute of Veterinary Preventive Medicine Product Introduction, Application and Specification
8.9.3 Institute of Veterinary Preventive Medicine Hemorrhagic Septicemia Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Intervac (PVT) Ltd
8.10.1 Intervac (PVT) Ltd Hemorrhagic Septicemia Vaccines Production Sites and Area Served
8.10.2 Intervac (PVT) Ltd Product Introduction, Application and Specification
8.10.3 Intervac (PVT) Ltd Hemorrhagic Septicemia Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 LABIOFAM
8.12 Laboratorios Laverlam
8.13 Laboratorios Ovejero
8.14 Limor de Colombia
8.15 National Veterinary Research Institute
8.16 Zoetis

9 Development Trend of Analysis of Hemorrhagic Septicemia Vaccines Market
9.1 Global Hemorrhagic Septicemia Vaccines Market Trend Analysis
9.1.1 Global Hemorrhagic Septicemia Vaccines Market Size (Volume and Value) Forecast 2019-2025
9.2 Hemorrhagic Septicemia Vaccines Regional Market Trend
9.2.1 North America Hemorrhagic Septicemia Vaccines Forecast 2019-2025
9.2.2 Europe Hemorrhagic Septicemia Vaccines Forecast 2019-2025
9.2.3 China Hemorrhagic Septicemia Vaccines Forecast 2019-2025
9.2.4 Japan Hemorrhagic Septicemia Vaccines Forecast 2019-2025
9.2.5 Southeast Asia Hemorrhagic Septicemia Vaccines Forecast 2019-2025
9.2.6 India Hemorrhagic Septicemia Vaccines Forecast 2019-2025
9.3 Hemorrhagic Septicemia Vaccines Market Trend (Product Type)
9.4 Hemorrhagic Septicemia Vaccines Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Hemorrhagic Septicemia Vaccines Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Hemorrhagic Septicemia Vaccines
Table Global Hemorrhagic Septicemia Vaccines Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Hemorrhagic Septicemia Vaccines Production Market Share by Types in 2018
Figure Oil–adjuvant Vaccines Product Picture
Figure Aluminum hydroxide-adjuvant Vaccines Product Picture
Table Global Hemorrhagic Septicemia Vaccines Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Hemorrhagic Septicemia Vaccines Consumption Market Share by Applications in 2018
Figure Cattle
Figure Buffaloes
Figure Global Hemorrhagic Septicemia Vaccines Revenue (Million USD) (2014-2025)
Figure Global Hemorrhagic Septicemia Vaccines Production (K Units) (2014-2025)
Figure North America Hemorrhagic Septicemia Vaccines Market Size (Million USD) (2014-2025)
Figure Europe Hemorrhagic Septicemia Vaccines Market Size (Million USD) (2014-2025)
Figure China Hemorrhagic Septicemia Vaccines Market Size (Million USD) (2014-2025)
Figure Japan Hemorrhagic Septicemia Vaccines Market Size (Million USD) (2014-2025)
Figure Southeast Asia Hemorrhagic Septicemia Vaccines Market Size (Million USD) (2014-2025)
Figure India Hemorrhagic Septicemia Vaccines Market Size (Million USD) (2014-2025)
Table Hemorrhagic Septicemia Vaccines Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Hemorrhagic Septicemia Vaccines in 2018
Figure Manufacturing Process Analysis of Hemorrhagic Septicemia Vaccines
Figure Industry Chain Structure of Hemorrhagic Septicemia Vaccines
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Hemorrhagic Septicemia Vaccines Manufacturing Plants Distribution
Table Hemorrhagic Septicemia Vaccines Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Hemorrhagic Septicemia Vaccines Capacity (K Units) of Major Manufacturers (2014-2019)
Table Hemorrhagic Septicemia Vaccines Production (K Units) of Major Manufacturers (2014-2019)
Table Hemorrhagic Septicemia Vaccines Production Market Share of Major Manufacturers (2014-2019)
Figure Hemorrhagic Septicemia Vaccines Production Share by Manufacturers in 2018
Table Hemorrhagic Septicemia Vaccines Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Hemorrhagic Septicemia Vaccines Revenue Market Share of Major Manufacturers (2014-2019)
Figure Hemorrhagic Septicemia Vaccines Revenue Share by Manufacturers in 2018
Table Hemorrhagic Septicemia Vaccines Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Hemorrhagic Septicemia Vaccines Production by Regions 2014-2019 (K Units)
Table Global Hemorrhagic Septicemia Vaccines Production Market Share by Regions 2014-2019
Figure Global Hemorrhagic Septicemia Vaccines Production Market Share by Regions in 2018
Table Global Hemorrhagic Septicemia Vaccines Revenue by Regions 2014-2019 (Million USD)
Table Global Hemorrhagic Septicemia Vaccines Revenue Market Share by Regions 2014-2019
Figure Global Hemorrhagic Septicemia Vaccines Revenue Market Share by Regions in 2018
Table Global Hemorrhagic Septicemia Vaccines Consumption by Regions 2014-2019 (K Units)
Table Global Hemorrhagic Septicemia Vaccines Consumption Market Share by Regions 2014-2019
Figure North America Hemorrhagic Septicemia Vaccines Production Growth Rate 2014-2019 (K Units)
Figure North America Hemorrhagic Septicemia Vaccines Revenue Growth Rate 2014-2019 (Million USD)
Table North America Hemorrhagic Septicemia Vaccines Production, Consumption Import and Export (K Units)
Figure Europe Hemorrhagic Septicemia Vaccines Production Growth Rate 2014-2019 (K Units)
Figure Europe Hemorrhagic Septicemia Vaccines Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Hemorrhagic Septicemia Vaccines Production, Consumption Import and Export (K Units)
Figure China Hemorrhagic Septicemia Vaccines Production Growth Rate 2014-2019 (K Units)
Figure China Hemorrhagic Septicemia Vaccines Revenue Growth Rate 2014-2019 (Million USD)
Table China Hemorrhagic Septicemia Vaccines Production, Consumption Import and Export (K Units)
Figure Japan Hemorrhagic Septicemia Vaccines Production Growth Rate 2014-2019 (K Units)
Figure Japan Hemorrhagic Septicemia Vaccines Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Hemorrhagic Septicemia Vaccines Production, Consumption Import and Export (K Units)
Figure Southeast Asia Hemorrhagic Septicemia Vaccines Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Hemorrhagic Septicemia Vaccines Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Hemorrhagic Septicemia Vaccines Production, Consumption Import and Export (K Units)
Figure India Hemorrhagic Septicemia Vaccines Production Growth Rate 2014-2019 (K Units)
Figure India Hemorrhagic Septicemia Vaccines Revenue Growth Rate 2014-2019 (Million USD)
Table India Hemorrhagic Septicemia Vaccines Production, Consumption Import and Export (K Units)
Figure Global Consumption Hemorrhagic Septicemia Vaccines Market Share by Application (2014-2019)
Figure Global Value (Consumption) Hemorrhagic Septicemia Vaccines Market Share by Application (2014-2019)
Table Bio-Labs (PVT) Limited Hemorrhagic Septicemia Vaccines Production Sites and Area Served
Table Bio-Labs (PVT) Limited Hemorrhagic Septicemia Vaccines Product Introduction, Application and Specification
Table Bio-Labs (PVT) Limited Hemorrhagic Septicemia Vaccines Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Bio-Labs (PVT) Limited Hemorrhagic Septicemia Vaccines Production Growth Rate (2014-2019)
Table Bio-Labs (PVT) Limited Hemorrhagic Septicemia Vaccines Production Market Share (2014-2019)
Figure Bio-Labs (PVT) Limited Hemorrhagic Septicemia Vaccines Revenue Market Share (2014-2019)
Table Bio-Labs (PVT) Limited Hemorrhagic Septicemia Vaccines Main Business and Markets Served
Table Brilliant Bio Pharma Hemorrhagic Septicemia Vaccines Production Sites and Area Served
Table Brilliant Bio Pharma Hemorrhagic Septicemia Vaccines Product Introduction, Application and Specification
Table Brilliant Bio Pharma Hemorrhagic Septicemia Vaccines Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Brilliant Bio Pharma Hemorrhagic Septicemia Vaccines Production Growth Rate (2014-2019)
Table Brilliant Bio Pharma Hemorrhagic Septicemia Vaccines Production Market Share (2014-2019)
Figure Brilliant Bio Pharma Hemorrhagic Septicemia Vaccines Revenue Market Share (2014-2019)
Table Brilliant Bio Pharma Hemorrhagic Septicemia Vaccines Main Business and Markets Served
Table C.A. Laboratorios Asociados (CALA) Hemorrhagic Septicemia Vaccines Production Sites and Area Served
Table C.A. Laboratorios Asociados (CALA) Hemorrhagic Septicemia Vaccines Product Introduction, Application and Specification
Table C.A. Laboratorios Asociados (CALA) Hemorrhagic Septicemia Vaccines Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table C.A. Laboratorios Asociados (CALA) Hemorrhagic Septicemia Vaccines Production Growth Rate (2014-2019)
Table C.A. Laboratorios Asociados (CALA) Hemorrhagic Septicemia Vaccines Production Market Share (2014-2019)
Figure C.A. Laboratorios Asociados (CALA) Hemorrhagic Septicemia Vaccines Revenue Market Share (2014-2019)
Table C.A. Laboratorios Asociados (CALA) Hemorrhagic Septicemia Vaccines Main Business and Markets Served
Table Ceva Santé Animale Hemorrhagic Septicemia Vaccines Production Sites and Area Served
Table Ceva Santé Animale Hemorrhagic Septicemia Vaccines Product Introduction, Application and Specification
Table Ceva Santé Animale Hemorrhagic Septicemia Vaccines Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Ceva Santé Animale Hemorrhagic Septicemia Vaccines Production Growth Rate (2014-2019)
Table Ceva Santé Animale Hemorrhagic Septicemia Vaccines Production Market Share (2014-2019)
Figure Ceva Santé Animale Hemorrhagic Septicemia Vaccines Revenue Market Share (2014-2019)
Table Ceva Santé Animale Hemorrhagic Septicemia Vaccines Main Business and Markets Served
Table Vecol Hemorrhagic Septicemia Vaccines Production Sites and Area Served
Table Vecol Hemorrhagic Septicemia Vaccines Product Introduction, Application and Specification
Table Vecol Hemorrhagic Septicemia Vaccines Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Vecol Hemorrhagic Septicemia Vaccines Production Growth Rate (2014-2019)
Table Vecol Hemorrhagic Septicemia Vaccines Production Market Share (2014-2019)
Figure Vecol Hemorrhagic Septicemia Vaccines Revenue Market Share (2014-2019)
Table Vecol Hemorrhagic Septicemia Vaccines Main Business and Markets Served
Table FATRO Hemorrhagic Septicemia Vaccines Production Sites and Area Served
Table FATRO Hemorrhagic Septicemia Vaccines Product Introduction, Application and Specification
Table FATRO Hemorrhagic Septicemia Vaccines Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table FATRO Hemorrhagic Septicemia Vaccines Production Growth Rate (2014-2019)
Table FATRO Hemorrhagic Septicemia Vaccines Production Market Share (2014-2019)
Figure FATRO Hemorrhagic Septicemia Vaccines Revenue Market Share (2014-2019)
Table FATRO Hemorrhagic Septicemia Vaccines Main Business and Markets Served
Table Indian Immunologicals Limited Hemorrhagic Septicemia Vaccines Production Sites and Area Served
Table Indian Immunologicals Limited Hemorrhagic Septicemia Vaccines Product Introduction, Application and Specification
Table Indian Immunologicals Limited Hemorrhagic Septicemia Vaccines Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Indian Immunologicals Limited Hemorrhagic Septicemia Vaccines Production Growth Rate (2014-2019)
Table Indian Immunologicals Limited Hemorrhagic Septicemia Vaccines Production Market Share (2014-2019)
Figure Indian Immunologicals Limited Hemorrhagic Septicemia Vaccines Revenue Market Share (2014-2019)
Table Indian Immunologicals Limited Hemorrhagic Septicemia Vaccines Main Business and Markets Served
Table Institute of Animal Health and Veterinary Biologicals Hemorrhagic Septicemia Vaccines Production Sites and Area Served
Table Institute of Animal Health and Veterinary Biologicals Hemorrhagic Septicemia Vaccines Product Introduction, Application and Specification
Table Institute of Animal Health and Veterinary Biologicals Hemorrhagic Septicemia Vaccines Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Institute of Animal Health and Veterinary Biologicals Hemorrhagic Septicemia Vaccines Production Growth Rate (2014-2019)
Table Institute of Animal Health and Veterinary Biologicals Hemorrhagic Septicemia Vaccines Production Market Share (2014-2019)
Figure Institute of Animal Health and Veterinary Biologicals Hemorrhagic Septicemia Vaccines Revenue Market Share (2014-2019)
Table Institute of Animal Health and Veterinary Biologicals Hemorrhagic Septicemia Vaccines Main Business and Markets Served
Table Institute of Veterinary Preventive Medicine Hemorrhagic Septicemia Vaccines Production Sites and Area Served
Table Institute of Veterinary Preventive Medicine Hemorrhagic Septicemia Vaccines Product Introduction, Application and Specification
Table Institute of Veterinary Preventive Medicine Hemorrhagic Septicemia Vaccines Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Institute of Veterinary Preventive Medicine Hemorrhagic Septicemia Vaccines Production Growth Rate (2014-2019)
Table Institute of Veterinary Preventive Medicine Hemorrhagic Septicemia Vaccines Production Market Share (2014-2019)
Figure Institute of Veterinary Preventive Medicine Hemorrhagic Septicemia Vaccines Revenue Market Share (2014-2019)
Table Institute of Veterinary Preventive Medicine Hemorrhagic Septicemia Vaccines Main Business and Markets Served
Table Intervac (PVT) Ltd Hemorrhagic Septicemia Vaccines Production Sites and Area Served
Table Intervac (PVT) Ltd Hemorrhagic Septicemia Vaccines Product Introduction, Application and Specification
Table Intervac (PVT) Ltd Hemorrhagic Septicemia Vaccines Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Intervac (PVT) Ltd Hemorrhagic Septicemia Vaccines Production Growth Rate (2014-2019)
Table Intervac (PVT) Ltd Hemorrhagic Septicemia Vaccines Production Market Share (2014-2019)
Figure Intervac (PVT) Ltd Hemorrhagic Septicemia Vaccines Revenue Market Share (2014-2019)
Table Intervac (PVT) Ltd Hemorrhagic Septicemia Vaccines Main Business and Markets Served
Table LABIOFAM Hemorrhagic Septicemia Vaccines Production Sites and Area Served
Table Laboratorios Laverlam Hemorrhagic Septicemia Vaccines Production Sites and Area Served
Table Laboratorios Ovejero Hemorrhagic Septicemia Vaccines Production Sites and Area Served
Table Limor de Colombia Hemorrhagic Septicemia Vaccines Production Sites and Area Served
Table National Veterinary Research Institute Hemorrhagic Septicemia Vaccines Production Sites and Area Served
Table Zoetis Hemorrhagic Septicemia Vaccines Production Sites and Area Served
Figure Global Hemorrhagic Septicemia Vaccines Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Hemorrhagic Septicemia Vaccines Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Hemorrhagic Septicemia Vaccines Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Hemorrhagic Septicemia Vaccines Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Hemorrhagic Septicemia Vaccines Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Hemorrhagic Septicemia Vaccines Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Hemorrhagic Septicemia Vaccines Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Hemorrhagic Septicemia Vaccines Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Hemorrhagic Septicemia Vaccines Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Hemorrhagic Septicemia Vaccines Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Hemorrhagic Septicemia Vaccines Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Hemorrhagic Septicemia Vaccines Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Hemorrhagic Septicemia Vaccines Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Hemorrhagic Septicemia Vaccines Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Hemorrhagic Septicemia Vaccines Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Hemorrhagic Septicemia Vaccines by Type (2019-2025)
Table Global Consumption (K Units) of Hemorrhagic Septicemia Vaccines by Application (2019-2025)
Table Hemorrhagic Septicemia Vaccines Distributors List
Table Hemorrhagic Septicemia Vaccines Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介

出血性ショック治療のグローバル市場調査 2019年

QYR9NV05966 2019年11月12日 107Pages
※本調査レポートは、出血性ショック治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、YW-356、NVX-408、ニュートロライド、LB-1148、その他に...

マールブルグ病治療薬のグローバル市場調査 2019年

Global Marburg Hemorrhagic Fever Drug Market Professional Survey Report 2019
QYR9NV07929 2019年11月14日 106Pages
※本調査レポートは、マールブルグ病治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、マールブルクワクチン、AVI-7288、TKM-マールブルク、その他に...

デング熱ワクチンのグローバル市場調査 2019年

Global Dengue Vaccines Market Professional Survey Report 2019
QYR9NV03407 2019年11月12日 101Pages
※本調査レポートは、デング熱ワクチンの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、CYD-TDV、Tak-003、その他に、用途別には、病院、政府機関、非政...

ヒトDNAワクチンのグローバル市場：規模・現状・予測2019-2025

Global Human DNA Vaccines Market Size, Status and Forecast 2019-2025
QYR9NV18016 2019年11月18日 96Pages
※当調査レポートでは、ヒトDNAワクチンの世界市場について調査・分析し、ヒトDNAワクチンの世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（組換えタンパク質ワクチン、遺伝子ベースワクチン）、用途別（イ...

ヒトDNAワクチンのグローバル市場：規模・現状・予測2019-2025

アフリカ馬疫(AHS)ワクチンのグローバル市場調査 2019年

Global African Horse Sickness Vaccines Market Professional Survey Report 2019
QYR9NV00270 2019年11月12日 103Pages
※本調査レポートは、アフリカ馬疫(AHS)ワクチンの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、生ワクチン、不活化ワクチンに、用途別には、馬、ラバ、ロバにセ...

髄膜炎菌ワクチンのグローバル市場調査 2019年

Global Meningococcal Vaccines Market Professional Survey Report 2019
QYR9NV08196 2019年11月14日 101Pages
※本調査レポートは、髄膜炎菌ワクチンの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、メナクトラ、メノムネに、用途別には、肺炎、髄膜炎、菌血症、その他（関節炎、...

治療ワクチンのグローバル市場調査 2019年

Global Therapeutic Vaccines Market Professional Survey Report 2019
QYR9NV13222 2019年11月16日 102Pages
※本調査レポートは、治療ワクチンの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ペプチド治療用ワクチン、細胞治療用ワクチン、核酸治療用ワクチンに、用途別には、...

治療ワクチンのグローバル市場調査 2019年

出血性ショック治療のグローバル市場調査 2019年 The global Hemorrhagic Shock Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Hemorrhagic Shock Treatment volume and value at global level, regional level and company level. From a global p…
デング熱ワクチンのグローバル市場調査 2019年 The global Dengue Vaccines market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Dengue Vaccines volume and value at global level, regional level and company level. From a global perspective, this report …
マールブルグ病治療薬のグローバル市場調査 2019年 The global Marburg Hemorrhagic Fever Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Marburg Hemorrhagic Fever Drug volume and value at global level, regional level and company level. From a gl…
ヒトDNAワクチンのグローバル市場：規模・現状・予測2019-2025 DNA vaccines have evolved greatly over the last 20 years since their invention, but have yet to become a competitive alternative to conventional protein or carbohydrate based human vaccines. Whilst safety concerns were an initial barrier, the Achilles heel of DNA vaccines remains their poor immunoge…
ヒトDNAワクチンのグローバル市場：規模・現状・予測2019-2025 DNA vaccines have evolved greatly over the last 20 years since their invention, but have yet to become a competitive alternative to conventional protein or carbohydrate based human vaccines. Whilst safety concerns were an initial barrier, the Achilles heel of DNA vaccines remains their poor immunoge…